Updated policy regarding electronic nicotine delivery systems

by Yale Cancer CenterPercentage of various school age groups who vaped in the past 30 days. Blue lines indicate data from the NYTS (51, 52, 54–60), and red lines indicate data from the MTF survey (53)

Updated on: January 30,2024

Updated policy regarding electronic nicotine delivery systems

by Yale Cancer CenterPercentage of various school age groups who vaped in the past 30 days. Blue lines indicate data from the NYTS (51, 52, 54–60), and red lines indicate data from the MTF survey (53)

Updated on:January 30,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on: October 21,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on:October 21,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on: January 29,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on:January 29,2024

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc

Updated on: March 27,2024

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc

Updated on:March 27,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on: April 10,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on:April 10,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on: March 30,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on:March 30,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on: December 28,2023

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on:December 28,2023

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024